The most common risks of oral GLP-1s like Rybelsus, Wegovy pill, and Foundayo include : Acute pancreatitis Diabetic retinopathy complications (diabetes-related vision changes) Hypoglycemia (low blood sugar), especially when used with insulin Kidney or gallbladder issues Severe gastrointestinal reactions Allergic reactions Pulmonary aspiration during general anesthesia or deep sedation All three GLP-1s also carry a black box warning for thyroid tumors based on animal studies
A new neck mass, changes in voice, difficulty swallowing, or persistent throat discomfort warrant medical attention regardless of what medication you take
there are no large independent randomized cardiovascular-outcome trials establishing clinical benefit in humans, which is the specific kind of evidence that would be required before any cardiac claim could be taken seriously in evidence-based cardiology
Legal rights vary by state, and filing deadlines are strict
A one-time $199 baseline lab at enrollment, six-month minimum ($894 total), then month-to-month with thirty days' written notice to cancel